or
forgot password
  • cancer clinical trials in latham, NY

  • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    New York Oncology Hematology, PC - Latham
    Latham, New York 12110
    Breast Cancer
    Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    Capitol District Hematology Oncology Associates, P.C.
    Latham, New York 12110-0610
    Colorectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    New York Oncology Hematology PC - Latham
    Latham, New York 12110
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    New York Oncology Hematology PC - Latham
    Latham, New York 12110
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    New York Oncology Hematology, PC - Latham
    Latham, New York 12110
    Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    New York Oncology Hematology PC - Latham
    Latham, New York 12110
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    New York Oncology Hematology, PC - Latham
    Latham, New York 12110
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    NY Oncology Hematology PC- Latham- Capital District Oncology Hematology
    Latham, New York 12110
    Breast Cancer
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    New York Oncology Hematology PC - Latham
    Latham, New York 12110
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
    Empire Neurology P.C.
    Latham, New York
    Multiple Sclerosis, Relapsing-Remitting
    Connect® MM- The Multiple Myeloma Disease Registry
    US Oncology - New York Oncology Hematology, PC-Latham
    Latham, New York 12110-0610
    Multiple Myeloma
    Study of PX-866 and Docetaxel in Solid Tumors
    New York Oncology, Hematology
    Latham, New York 12110
    Non Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    New York Oncology Hematology PC - Latham
    Latham, New York 12110
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    New York Oncology Hematology PC - Latham
    Latham, New York 12110
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    New York Oncology Hematology PC - Latham
    Latham, New York 12110
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    New York Oncology Hematology, P.C. - Latham
    Latham, New York 12110-0610
    Breast Cancer
    A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.
    "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
    Latham, New York
    Colorectal Cancer
    Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer
    New York Oncology-Hematology,P.C./Capital District Hematology, Oncology Associates
    Latham, New York 12110
    Carcinoma, Non-Small-Cell Lung
    Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease
    New York Oncology/Hematology PC
    Latham, New York 12110
    Gaucher Disease, Type 1, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease, Gaucher Disease, Non-Neuronopathic Form
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
    Empire Neurology PC
    Latham, New York
    Multiple Sclerosis, Relapsing-Remitting
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    Empire Neurology PC
    Latham, New York
    Multiple Sclerosis, Relapsing-Remitting
    Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
    New York Oncology Hematology-Oncology Associates, P.C.
    Latham, New York 12110
    Non-small Cell Lung Cancer
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    New York Oncology Hematology PC - Latham
    Latham, New York 12110
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer